This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Università Degli Studi Di Roma "La Sapienza", Fondazione Istituto Italiano Di Tecnologia, Universitá Degli Studi Di Siena. Active years: 2018-2021.
Location History:
- Rome, IT (2018)
- Castelnuovo Berardegna, IT (2021)
Company Filing History:
2 out of 63 
1 out of 146 
1 out of 18 Years Active: 2018-2021
Title: Mattia Mori: Innovator in Cancer Treatment
Introduction
Mattia Mori is a notable inventor based in Castelnuovo Berardenga, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. With a total of 2 patents, Mori's work focuses on addressing critical health challenges, particularly in oncology.
Latest Patents
Mori's latest patents include groundbreaking inventions aimed at treating T-cell acute lymphoblastic leukemia (T-ALL). The first patent, titled "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia," involves compounds of formula (I) that exhibit anti-tumor activity. The second patent, "Multitarget hedgehog pathway inhibitors and uses thereof," concerns compounds that selectively inhibit the Hedgehog (Hh) pathway, which is crucial in treating Hh-dependent tumors such as medulloblastoma (MB).
Career Highlights
Throughout his career, Mattia Mori has worked with prestigious institutions, including the University of Rome "La Sapienza" and the Italian Institute of Technology. His research has contributed to advancements in cancer therapies, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Mori has collaborated with esteemed colleagues, including Bruno Botta and Cinzia Ingallina. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatments.
Conclusion
Mattia Mori's contributions to cancer treatment through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for innovative therapies that address critical health issues.